2008 ICD-9-CM Volume 1 Diagnosis Codes Home > Endocrine, Nutritional And Metabolic Diseases, And Immunity Disorders 240-279 > Other Metabolic Disorders And Immunity Disorders 270-279 > Disorders Of Mineral Metabolism 275.* >  2008 ICD-9-CM Diagnosis 275.49
Other disorders of calcium metabolism On October 1, 2008 the 2009 ICD-9-CM codes came into effect. Therefore, this code may be out of date.
The 2009 version of ICD-9-CM 275.49 can be accessed here. - A condition characterized by precipitation of calcium phosphate in the tubules of the kidney, with resultant renal insufficiency. (Dorland, 27th ed)
- A genetically related form of PSEUDOHYPOPARATHYROIDISM characterized by the same features except for the abnormal response to parathyroid hormone.
- A hereditary condition clinically resembling HYPOPARATHYROIDISM, but caused by failure of response to rather than deficiency of parathyroid hormones. It is characterized by hypocalcemia and hyperphosphatemia, and is commonly associated with short stature, obesity, short metacarpals, and ectopic calcification. (Dorland, 27th ed)
- Originally reported as a hypocalcemic syndrome similar to hypoparathyroidism, but with renal and skeletal resistance to parathyroid hormone (PTH) and designated as "pseudohypoparathyroidism." Albright later defined a normocalcemic variant which he termed "pseudopseudohypoparathyroidism." Two separate forms of pseudohypoparathyroidism are recognized. Type I in which there is no increase in the urinary excretion of cyclic adenosine monophosphate (cAMP) and phosphate in response to parathyroid hormone (PTH). Type II in which there is a response to PTH, but without phosphate diuresis. The erythrocytes of some patients with type I contain a defective receptor-cyclase coupling protein (stimulatory guanine nucleoside-binding protein, or GS) which is responsible for coupling the cellular receptor that binds parathyroid hormone (PTH) and is involved with the formation and release of cyclic adenosine monophosphate (cAMP). This variant has been designated as "pseudohypoparathyroidism type Ia." The syndrome is associated with mental deficiency, dystrophic bone lesions, short stature, and other defects.
- 275.49 is a specific code that can be used to specify a diagnosis
- 275.49 contains 16 index entries
- View the ICD-9-CM Volume 1 275.* hierarchy
275.49 also known as:- Nephrocalcinosis
- Pseudohypoparathyroidism
- Pseudopseudohypoparathyroidism
Index entries containing 275.49:- Albright (-Martin) (-Bantam) disease (pseudohypoparathyroidism)
 275.49
Bantam-Albright-Martin disease (pseudohypoparathyroidism) 275.49
Calcinosis (generalized) (interstitial) (tumoral) (universalis) 275.49- circumscripta 709.3
- cutis 709.3
- intervertebralis 275.49 [722.90]
- Raynaud's phenomenonsclerodactylytelangiectasis (CRST) 710.1
Calciphylaxis (see also Calcification, by site) 275.49
Degeneration, degenerative- calcareous NEC 275.49
Disease, diseased - see also Syndrome- Albright (-Martin) (-Bantam) 275.49
Infiltrate, infiltration- calcareous (muscle) NEC 275.49
- localized - see Degeneration, by site
- calcium salt (muscle) 275.49
Martin-Albright syndrome (pseudohypoparathyroidism) 275.49
Nephrocalcinosis 275.49
Pseudohypoparathyroidism 275.49
Pseudopseudohypoparathyroidism 275.49
Seabright-Bantam syndrome (pseudohypoparathyroidism) 275.49
Syndrome - see also Disease- Albright (-Martin) (pseudohypoparathyroidism) 275.49
- Martin-Albright (pseudohypoparathyroidism) 275.49
- Seabright-Bantam (pseudohypoparathyroidism) 275.49
|
|
|
